Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Inverted hammer
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by puma1on Jun 16, 2016 9:49am
212 Views
Post# 24970633

RE:RE:RE:RE:RE:RE:Inverted hammer

RE:RE:RE:RE:RE:RE:Inverted hammer
fdfd12 wrote: The BIG SHORTS are betting that CXR will miss guidance by future UK gov't 
drug price control (forcing prices lower) and things we are hearing like part of
Donnatal not being FDA approved.

They are betting these things will play out and hurt CXR and then snowballing one
after the other.




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities